SAMDaily.us | PRESOL | 65 | Recombinant West Nile Virus NS2B-NS3 protease � 5mg

SAMDAILY.US - ISSUE OF JULY 20, 2022 SAM #7537
SOLICITATION NOTICE

65 -- Recombinant West Nile Virus NS2B-NS3 protease � 5mg

Notice Date: 7/18/2022 1:08:16 PM
Notice Type: Combined Synopsis/Solicitation
NAICS: 325414 — Biological Product (except Diagnostic) Manufacturing
Contracting Office: NATIONAL INSTITUTES OF HEALTH NCATS BETHESDA MD 20892 USA
ZIP Code: 20892
Solicitation Number: 75N95C22Q00003
Response Due: 7/22/2022 8:00:00 AM
Archive Date: 08/06/2022
Point of Contact: Stuart Kern
E-Mail Address: stuart.kern@nih.gov
(stuart.kern@nih.gov)
Description: The National Center for Advancing Translational Sciences (NCATS) intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to R&D Systems Inc., 614 McKinley Place NE, Minneapolis, MN 55413 for 5mg of recombinant West Nile Virus NS2B-NS3 protease. The anticipated award date is 7/22/2022. This acquisition is non-competitive due to the requirement to ensure compatibility in all aspects (form, fit, and function) to ensure consistency and continuity of results in ongoing scientific studies. See the attached combined synopsis/solicitation for full details.
Web Link: SAM.gov Permalink
(https://sam.gov/opp/e7013ebe86334a78b8491c7eb57fc703/view)
Place of Performance: Address: Minneapolis, MN 55413, USA; Zip Code: 55413; Country: USA
Record: SN06392797-F 20220720/220718230101 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |